| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Feb 4, 2025 | aTYR PHARMA INC | General Counsel | Sell | 47.5 | -899 | -3.27% | ✗ | $3.4K |
| Jun 5, 2024 | Jun 6, 2024 | aTYR PHARMA INC | General Counsel | Buy | 90.0 | +5,000 | 28.96% | ✗ | $9.3K |
| May 16, 2020 | May 28, 2020 | aTYR PHARMA INC | General Counsel | Sell | 30.0 | -322 | -10.53% | ✓ | $1.2K |
| May 16, 2019 | May 20, 2019 | aTYR PHARMA INC | General Counsel | Sell | 25.0 | -4,651 | -15.50% | ✓ | $2.1K |